feed,title,long_url,short_url
Benzinga,"Biogen Revises Annual Forecast As Reata M&A And Alzheimer's Drug Expenses Hit Bottomline, Stock Slides",https://benzinga.com/general/biotech/23/11/35673203/biogen-revises-annual-forecast-as-reata-m-a-and-alzheimers-drug-expenses-hit-bottomline-stock-sli,https://da.gd/AiPd0Z
